GL1X · GenesisL1 explorer

MolNFT v1 · #129905 · protein

VSV G CR3

5OY9 · Glycoprotein G: “VSV G CR3”. X-ray diffraction, 2 ligands (NAG, CA), 6 pockets (best druggability 0.69). MolNFT v1 #129905 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5OY9
Type
protein
Length
447 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycoprotein G; Low-density lipoprotein receptor
UniProt
P0C2X0, P01130
Ligands
NAG, CA
Pockets
6 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 15% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycoprotein Gprotein41016% helix, 36% strandP0C2X0
DLow-density lipoprotein receptorprotein378% helix, 16% strandP01130

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A
  • CA · Calcium ion · metal · 4 copies · chains A, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1560.690.9716empty
21080.570.8519empty
31460.430.7531empty
4840.370.7614empty
5950.360.7518empty

Interfaces

1 interface between chains.

  • A–D · 772 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 9 disulfide, 2 glycan, 1 modified (disulfide, N-glycosylation, methylation).

Compared structures

  • P01130 · AlphaFold monomer V2.0 prediction for low-density lipoprotein receptor (P01130) · a predicted model of the same protein · chain D against A, TM-score 0.84

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.